5.
Sim Y, Lee J, Lee E, Choi J, Lee C, An T
. COPD Exacerbation-Related Pathogens and Previous COPD Treatment. J Clin Med. 2023; 12(1).
PMC: 9821136.
DOI: 10.3390/jcm12010111.
View
5.
Jung H, Ra M, Bae H, Hong S
. The LDL-C/Apo B predicts coronary atherosclerotic heart disease in non-diabetic patients without high LDL-C. Medicine (Baltimore). 2023; 102(1):e32596.
PMC: 9829249.
DOI: 10.1097/MD.0000000000032596.
View
6.
Bodaghi A, Ebadi E, Gholami M, Azizi R, Shariati A
. A decreased level of high-density lipoprotein is a possible risk factor for type 2 diabetes mellitus: A review. Health Sci Rep. 2023; 6(12):e1779.
PMC: 10731824.
DOI: 10.1002/hsr2.1779.
View
7.
Neuhouser M, Aragaki A, Prentice R, Manson J, Chlebowski R, Carty C
. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials. JAMA Oncol. 2015; 1(5):611-21.
PMC: 5070941.
DOI: 10.1001/jamaoncol.2015.1546.
View
8.
Waters J, Ley R
. The human gut bacteria Christensenellaceae are widespread, heritable, and associated with health. BMC Biol. 2019; 17(1):83.
PMC: 6819567.
DOI: 10.1186/s12915-019-0699-4.
View
9.
El Amrawy A, Almaghraby A, Abdelnabi M
. The prognostic impact of HDL-C level in patients presenting with ST-elevation myocardial infarction. Br J Cardiol. 2023; 30(1):5.
PMC: 10495758.
DOI: 10.5837/bjc.2023.005.
View
10.
Lee C, Wang G, Pertsinidis A, Marians K
. Topoisomerase III Acts at the Replication Fork To Remove Precatenanes. J Bacteriol. 2019; 201(7).
PMC: 6416919.
DOI: 10.1128/JB.00563-18.
View
11.
Liu G, Wang X, Su H, Lu G
. Progress on the GntR family transcription regulators in bacteria. Yi Chuan. 2021; 43(1):66-73.
DOI: 10.16288/j.yczz.20-245.
View
12.
Wang C, Zhou Y, Huang W, Chen Z, Zhu H, Mao F
. The impact of pre-existed and SERM-induced non-alcoholic fatty liver disease on breast cancer survival: a meta-analysis. J Cancer. 2020; 11(15):4597-4604.
PMC: 7255364.
DOI: 10.7150/jca.44872.
View
13.
Luan B, Ge F, Lu X, Li Z, Zhang H, Wu J
. Changes in the fecal microbiota of breast cancer patients based on 16S rRNA gene sequencing: a systematic review and meta-analysis. Clin Transl Oncol. 2024; 26(6):1480-1496.
DOI: 10.1007/s12094-023-03373-5.
View
14.
Effendi R, Anshory M, Kalim H, Dwiyana R, Suwarsa O, Pardo L
. and in Immune-Related Diseases. Microorganisms. 2022; 10(12).
PMC: 9782003.
DOI: 10.3390/microorganisms10122382.
View
15.
Li Y, Deng Q, Liu Z
. The relationship between gut microbiota and insomnia: a bi-directional two-sample Mendelian randomization research. Front Cell Infect Microbiol. 2023; 13:1296417.
PMC: 10714008.
DOI: 10.3389/fcimb.2023.1296417.
View
16.
Bray F, Laversanne M, Sung H, Ferlay J, Siegel R, Soerjomataram I
. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74(3):229-263.
DOI: 10.3322/caac.21834.
View
17.
An J, Kwon H, Kim Y
. The Role of Blood Microbiome in the Development of Thyroid Cancer in Breast Cancer Survivors. Cancers (Basel). 2023; 15(18).
PMC: 10526815.
DOI: 10.3390/cancers15184492.
View
18.
Sui Y, Liu Q, Xu C, Ganesan K, Ye Z, Li Y
. Non-alcoholic fatty liver disease promotes breast cancer progression through upregulated hepatic fibroblast growth factor 21. Cell Death Dis. 2024; 15(1):67.
PMC: 10796330.
DOI: 10.1038/s41419-023-06386-8.
View